Related Experiment Video
Updated: May 11, 2026

Detection of True IgE-expressing Mouse B Lineage Cells
Published on: December 1, 2014
The biology of the eosinophilic leukocyte
G J Gleich1, C R Adolphson, K M Leiferman
1Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
Abstract:
The eosinophil is characterized by specific cytoplasmic granules that contain a series of cationic toxins able to kill many targets, including helminths, protozoa, bacteria, and other cells. In bronchial asthma, considerable evidence exists that the eosinophil releases granule proteins, especially the major basic protein (MBP), which in turn mediate tissue abnormalities. Among eosinophil-activating factors, IL-5 has been associated with helminth infection and hypersensitivity diseases and would appear to be an attractive target for pharmacological intervention.
Insights
Eosinophils release toxic granule proteins, like major basic protein (MBP), causing tissue damage in asthma. Interleukin-5 (IL-5) is a key factor in these diseases, making it a potential drug target.
Area of Science:
- Immunology
- Cell Biology
Background:
- Eosinophils possess unique granules with cationic toxins effective against pathogens and host cells.
- In bronchial asthma, eosinophil granule proteins, particularly major basic protein (MBP), are implicated in tissue damage.
Purpose of the Study:
- To highlight the role of eosinophils and their products in asthma pathogenesis.
- To identify Interleukin-5 (IL-5) as a significant eosinophil activator and potential therapeutic target.
Main Methods:
- Review of existing literature on eosinophil function and asthma.
- Analysis of the role of Interleukin-5 (IL-5) in hypersensitivity and helminth infections.
Main Results:
- Eosinophils release cytotoxic granule proteins that mediate asthma-related tissue abnormalities.
- Interleukin-5 (IL-5) is strongly associated with helminth infections and hypersensitivity diseases, driving eosinophil activation.
Conclusions:
- Eosinophil granule proteins are key mediators of asthma pathology.
- Targeting Interleukin-5 (IL-5) presents a promising therapeutic strategy for managing asthma and related conditions.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Structure and Function of Leukocytes
White blood cells protect the body...
Classification of Leukocytes
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Asthma I: Introduction

